Colorectal Cancer Trial, Recruiting NCT07337590 Sponsor: Exero Medical Ltd. Condition: Colorectal Cancer
Back to Colorectal Cancer

Colorectal Cancer Trial, Recruiting

NCT07337590
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Interventional group (active participants):

  • Adults aged 21 or older who are scheduled for a planned bowel surgery called a low anterior resection, due to colorectal cancer
  • People whose surgical join (anastomosis) in the bowel is expected to be made within 10 cm of the opening of the back passage
  • People whose surgery is expected to involve the use of a surgical drain (this is confirmed during the operation)
  • People who are willing to attend follow-up visits and able to give their informed consent to participate

Historical group (past medical records review):

  • Adults aged 21 or older at the time of their bowel surgery
  • People who previously had a low anterior resection for colorectal cancer
  • People whose records show the bowel join or tumour was located within 10 cm of the back passage opening, with complete medical records covering their hospital stay and 12 months of follow-up, or up until a stoma reversal procedure, whichever came first

Who may not be able to join:

Interventional group:

  • People whose bowel condition is non-cancerous (benign)
  • People for whom surgery or general anaesthetic is medically not safe
  • People who are known to be pregnant or breastfeeding
  • People who receive a protective stoma (a temporary bag) during the surgery (confirmed during the operation)
  • People who have an electronic device implanted in the chest or abdomen, such as a pacemaker or defibrillator
  • People with a significant medical or psychiatric condition, or other health factors, that may affect their ability to attend follow-up appointments
  • People with a known allergy to silicone, rubber, or stainless steel, which are materials used in the study device (the xBar system)
  • People who are already participating in another interventional clinical study while the xBar device is in use

Historical group:

  • People whose past surgery was performed for a non-cancerous reason, such as diverticulitis, inflammatory bowel disease, non-cancerous narrowing of the bowel, or a fistula

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +972547545065

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Exero Medical Ltd.
Registry
ClinicalTrials.gov
Start date
10 March 2026
Est. completion
1 December 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Primary Effectiveness Endpoint-Demonstrate non-inferiority between the study interventional and historical cohorts; Primary Safety Endpoint - No Unexpected Serious Adverse Device Events within the Intent to Treat population during the study period ( up to 365 days following index surgery)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov